FDA to Issue Severe COVID-19 Vaccine Warnings

Summary of Concerns Regarding ‍FDA & HHS Handling of Potential Vaccine-Related Deaths:

this article excerpt details⁢ concerns about the FDA adn HHS’s handling of potential links between COVID-19 vaccines and pediatric deaths. Here’s a breakdown of the key issues:

* Lack of Transparency: The FDA has not publicly released data connecting ⁤the COVID-19 vaccines to the reported pediatric deaths. This lack of details fuels concerns and distrust.
* Absence of Recommended Safety Measures: The article states that the FDA did not take⁣ recommended safety steps, specifically:
⁢* Convene an ⁢advisory committee of independent experts to review safety data.
* Publicly review the safety data.
* Concerns about Due process & Scientific Rigor: Experts like⁢ Dr. ⁣Kesselheim believe the decisions are being⁣ driven by “policy objectives” rather than a “rigorous and thoughtful‍ public review of the science.” ⁢There’s a feeling that there isn’t a fair prospect to debate the data.
* ‍ Government Interference: Dr.Fiona Havers, a former CDC epidemiologist, resigned due to “government interference” in vaccination programs, adding to concerns about the‍ objectivity of the process.
* one-Sided Communication: The article criticizes the⁤ focus on ⁣potential vaccine harms without also highlighting the benefits (hospitalizations and deaths prevented by the vaccines), calling it ⁤”irresponsible.”

In essence, the‍ core complaint is a perceived lack of transparency, independent review, and balanced communication surrounding potential adverse events related to the COVID-19 vaccine, specifically in pediatric cases. The HHS defends its process, stating decisions are based on “rigorous, independent evaluation of the data,” but this is countered by the experts’ claims of a⁢ lack‍ of public scrutiny and data release.